Similar genetic alterations have also been demonstrated in recent studies suggesting that the pathology of DE lymphomas reflect cumulative mutations involving B-cell receptor signaling and NF-kB [28, 30, 31]. The gene discussed is NFKB1; the disease is lymphoma.